Simultaneous acquisition of bone scintigraphy and 131I whole body scintigraphy after ablation therapy technician protocol

被引：0
|
作者：
Almeida, A. I. F. R. [1 ]
Ferreira, P. [1 ]
Oliveira, C. [1 ]
Oliveira, S. [1 ]
Neto, J. [1 ]
机构：
[1] Portuguese Canc Inst Francisco Gentil, Coimbra, Portugal
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2007年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S402 / S402
页数：1
相关论文
共 50 条
  • [21] The combination of 18F-FDG PET, 201Tl scintigraphy, and 131I scintigraphy improves the rate of detecting differentiated thyroid cancer undergoing 131I therapy after total thyroidectomy.
    Kato, K
    Iwano, S
    Tadokoro, M
    Ikeda, M
    Kobayashi, H
    Nishino, M
    Abe, S
    Nakayama, Y
    Nakano, S
    Ishigaki, T
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 327P - 327P
  • [22] Utility of Delayed Whole-Body Bone Scintigraphy After Directed Three-Phase Scintigraphy
    Davenport, Matthew S.
    Brown, Richard K. J.
    Frey, Kirk A.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2009, 193 (02) : 338 - 342
  • [23] Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole-body scan?
    Salvatori, M
    Perotti, G
    Rufini, V
    Maussier, ML
    Dottorini, M
    CLINICAL ENDOCRINOLOGY, 2004, 61 (06) : 704 - 710
  • [24] Radioiodine Uptake at Suture Site Granuloma Mimicking Neck Node Metastasis on 131I Whole-Body Iodine Scintigraphy
    Singh, Parneet
    Agrawal, Kanhaiyalal
    Patel, Ranjan Kumar
    Patro, P. Sai Sradha
    Parida, Girish Kumar
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (06) : e301 - e303
  • [25] Prognostic Value of Thyroglobulin Levels and Therapeutic 131I Whole-Body Scan after Initial 131I Ablation of Differentiated Thyroid Cancer
    Luo, Q.
    Yu, Y.
    Lu, H.
    Zhu, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S241 - S241
  • [26] Whole body scintigraphy after recombinant human TSH administration in differentiated thyroid cancer:: Comparison of imaging at 38 and 72 hours after 131I administration.
    Sarkar, SD
    Love, C
    Palestro, CJ
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 307P - 307P
  • [27] Predicting post-treatment persistent/metastatic disease by 131I whole-body scintigraphy in patients with differentiated thyroid cancer
    Volpe, F.
    Megna, R.
    Nappi, C.
    Zampella, E.
    Gaudieri, V.
    Piscopo, L.
    Di Donna, E.
    Petretta, M.
    Cuocolo, A.
    Klain, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S78 - S79
  • [28] Comparison of whole-body 18F-FDG SPECT and posttherapeutic 131I scintigraphy in the detection of metastatic thyroid cancer
    Wang, Hui
    Fu, Hong Liang
    Li, Ha Ning
    Zhou, Ren Han
    Gu, Zhen Hui
    Wu, Jing Chuan
    Huang, Gang
    CLINICAL IMAGING, 2008, 32 (01) : 32 - 37
  • [29] Concurrent Benign Iodine-Avid Thymic and Liver Cysts Mimicking Metastatic Disease on 131I Whole-Body Scintigraphy
    Kamarulzaman, Kamalia
    Rohani, Mohd Fazrin Mohd
    Nawi, Norazlina Mat
    Hassan, Siti Zarina Amir
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (03) : 250 - 252
  • [30] 99mTc-Sestamibi and 131I whole-body scintigraphy and initial serum thyroglobulin in the management of differentiated thyroid carcinoma
    Ng, DCE
    Sundram, FX
    Sin, AE
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (04) : 631 - 635
12345